Evolving Treatment Landscape of Psoriasis. More than Skin Deep.
December 2, 2019
Upcoming / RECENT Talks

Evolving Treatment Landscape of Psoriasis. More than Skin Deep. 

with Dr. Joel M. Gelfand
Dec 12, 2019, 11 AM ET
RSVP
Psoriasis is one of the most common skin ailments, affecting about 2 percent of the population, across gender, age or socioeconomic status. The impact of this autoimmune skin condition goes much deeper with raised cardiovascular risk, inflammatory arthritis and other immune system related conditions. The severity of the condition determines the treatment approach ranging from topical treatments to phototherapy. We are discussing Psoriasis treatment approaches with dermatologist Dr. Joel M. Gelfand.
Panelists
Dr Joel M. Gelfand
Howard Chang 
David Stanley
Priya Menon
Nov 7, 2019, 6 PM ET
LISTEN
PCOS is a little understood life changing syndrome. What we know about PCOS are the disturbing symptoms it creates in our bodies, but we only know the tip of the iceberg when it comes to reasons behind why these symptoms occur. Moreover, almost 70% of teenage girls/women remain undiagnosed mainly because they dont understand their symptoms and avoid discussing them. We talked to Dr Carolyn Alexander of Southern California Reproductive Center, about new developments in PCOS symptom management & treatment and PCOS updates from recently held #ASRM2019 Conference. Dr. Alexander has conducted extensive research on PCOS and specializes in the treatment of patients facing the diagnosis of PCOS and infertility. Guiding the discussion from the patient panel is Ashley Levinson @PCOSgurl who has been advocating for PCOS since the last 20 years. Michelle Shwarz, a PCOS patient and researcher, also joins the panel to discuss about funding and gaps in research in the field of PCOS.
Panelists
Dr Carolyn Alexander
Ashley Levinson
Michelle Shwarz
Shweta Mishra
Oct 10, 2019, 11:30 AM ET
LISTEN
Breast cancer is the second most common cancer in women (although men can get it too). Some breast cancers are driven by inherited mutations while most are sporadic, driven by unknown causes or by environmental or behavioral factors like obesity, lack of exercise, or alcohol use. Breast cancer screening aims to reduce the number of women who die from the disease and the statistics tell us that even though the rates of breast cancer now are greater than they were in the early 1980s, fewer women are dying from the disease. However, the scientific evidence backing screening's benefits is mixed. We are talking to Dr. Esserman of UCSF Helen Diller Family Comprehensive Cancer Center about developments in breast cancer screening and new treatments. 

 



Panelists
Dr Laura J Esserman
April Stearns
Kelsey Smith
Priya Menon 
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks
Avatar
TrialX Editor
powerfunction@gmail.com